Evidence map›Paper›PMID 15673772›Full record

Trial reportAntimicrobial agents and chemotherapy2005

Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Ebbing Lautenbach, Anthony D Harris, Eli N Perencevich, Irving Nachamkin, Pam Tolomeo, Joshua P Metlay

Abstract readClinical TrialComparative Study
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  13. Article
  14. Article
  15. Healthcare personnel intestinal colonization with multidrug-resistant organisms.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2018
    Observational
  16. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  17. Article
  18. Act Fast as Time Is Less: High Faecal Carriage of Carbapenem-ResistantJournal of clinical and diagnostic research : JCDR · 2016
    Article
  19. Antimicrobial resistance acquisition after international travel in U.S. travelers.Tropical diseases, travel medicine and vaccines · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ebbing LautenbachDivision of Infectious Diseases, Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. elautenb@cceb.med.upenn.edu
Anthony D Harris
Eli N Perencevich
Irving Nachamkin
Pam Tolomeo
Joshua P Metlay

Funding

CTRS FOR EDUCATION AND RESEARCH ON THERAPEUTICS (CERTS)U18HS010399 · AHRQ · UNIVERSITY OF PENNSYLVANIA · PI STROM, BRIAN LESLIE · 2000 to 2006
$800k
AHRQ HHS U18 HS010399AHRQ HHS U18-HS10399DRS NIH HHS RS1/CCR320627-01
6 · The paper itself

Abstract

Among 63 patients enrolled in a prospective cohort study of gut colonization with fluoroquinolone-resistant Escherichia coli, the sensitivity of perirectal swab compared to stool sample was 90% (95% confidence interval [CI], 70 to 99%) and the specificity was 100% (95% CI, 91 to 100%). For rectal swab, the sensitivity was 90% (95% CI, 68 to 99%) and the specificity was 100% (95% CI, 91 to 100%).

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsCohort StudiesCross-Sectional StudiesDigestive SystemEscherichia coliFecesFemaleFluoroquinolonesHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsFluoroquinolones

Identifiers

PMID15673772
PMCPMC547369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.